Changing Lives, One Step at a Time: HyProCure® Marks 8 Years

HyProCure^® was invented by Michael E. Graham, DPM, FACFAS, FAENS. In his practice, Dr. Graham specialized in the correction of foot and ankle instability. Recognizing the significant limitations of the sinus tarsi implants on the market, he developed HyProCure^®. The device received FDA approval on September 16, 2004 and the first HyProCure^® placement took place on September 22, 2004. As more and more doctors and patients gained awareness of both the condition and treatment, GraMedica^®, global orthopedic medical device company and maker of HyProCure^®, experienced rapid growth.

Dr. Graham was determined to improve patient outcomes by providing this revolutionary solution. In order to share his knowledge and expertise with other foot and ankle surgeons, he founded the Graham International Implant Institute^® (GIII^®) in August 2006. The mission of GIII^® is to elevate the standard of care in the arena of Extra-Osseous TaloTarsal Stabilization through education. Since the release of HyProCure^®, many peer-reviewed studies have been published recognizing the proven results of this EOTTS device. Learn more at http://www.gramedica.com/library/.